Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Lung Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04362150
What this trial is testing

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

Who this might be right for
COVID
University of California, San Francisco 800
Not applicableLooking for participantsNCT06691399
What this trial is testing

Role of Oral Care in Prevention of Nosocomial Pneumonia Among COPD Patients

Who this might be right for
Nosocomial PneumoniaCOPD Exacerbation
Assiut University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06619561
What this trial is testing

Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Who this might be right for
Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC 48
Not applicableUnknownNCT05851846
What this trial is testing

Amygdala Insula Retraining in the Management of Long COVID Symptoms

Who this might be right for
Long COVID
Miami VA Healthcare System 130
Post-approval studies (Phase 4)Study completedNCT04792567
What this trial is testing

Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)

Who this might be right for
Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals 41
Not applicableStudy completedNCT05866211
What this trial is testing

Lung Function in Post-COVID-19 Nursing Home Residents

Who this might be right for
Post-COVID-19 Syndrome
University of Vic - Central University of Catalonia 184
Large-scale testing (Phase 3)Ended earlyNCT04636801
What this trial is testing

A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 4,710
Not applicableStudy completedNCT03443479
What this trial is testing

Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure

Who this might be right for
Respiratory FailureRespiratory InsufficiencyRespiratory Tract Diseases+4 more
Hôpital de Verdun 324
Not applicableStudy completedNCT05624840
What this trial is testing

Safety and Clinical and Virologic Outcomes in CKD Patients Treated With Nirmatrelvir-ritonavir

Who this might be right for
COVID-19Chronic Kidney Disease stage4Chronc Kidney Disease Stage 5
Chinese University of Hong Kong 85
Large-scale testing (Phase 3)Study completedNCT00114361
What this trial is testing

48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B
Foundation for Liver Research 138
Early research (Phase 1)Study completedNCT01371162
What this trial is testing

RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 42
Not applicableStudy completedNCT00147017
What this trial is testing

Regulation of the Release of Inflammatory Mediators From Lung Macrophages.

Who this might be right for
COPDChronic BronchitisEmphysema
Imperial College London 17
Not applicableUnknownNCT05343962
What this trial is testing

Health Indicators and Patient Reported Outcomes. Identification of Significative Items Aimed at Improving Health Care Procceses.

Who this might be right for
Parkinson DiseaseDiabetes MellitusCOVID-19+2 more
Instituto de Biomecanica de Valencia 250
Early research (Phase 1)Study completedNCT05181683
What this trial is testing

COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT06437223
What this trial is testing

Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)

Who this might be right for
Long COVID
Inflammx Therapeutics Inc 16
Not applicableStudy completedNCT04525742
What this trial is testing

COVID-19 Pandemic and Parents of Disabled Children

Who this might be right for
COVID-19Disabilities MultipleCerebral Palsy+1 more
Gaziosmanpasa Research and Education Hospital 309
Not applicableStudy completedNCT05042063
What this trial is testing

Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease

Who this might be right for
CoughCOPDGERD+4 more
Clinica Universidad de Navarra, Universidad de Navarra 616
Not applicableStudy completedNCT06620406
What this trial is testing

Synbiotic Therapy for NP-PASC

Who this might be right for
Post-Acute COVID-19 SyndromeLong COVID-19
Columbia University 36
Not applicableStudy completedNCT05477199
What this trial is testing

Physiotherapy in Post COVID-19 Syndrome Patients

Who this might be right for
Post-COVID-19 Syndrome
Universidad de Granada 54
Not applicableLooking for participantsNCT04645511
What this trial is testing

Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.

Who this might be right for
Maxillary SinusitisSinusitis, ChronicSinusitis Recurrent+1 more
Tampere University Hospital 120
Next Page